RenovoRx Inc RNXT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:33 PM EDT
1.42quote price arrow down-0.03 (-2.07%)
Volume
4,840
52 week range
0.53 - 3.29
Loading...
  • Open1.37
  • Day High1.44
  • Day Low1.36
  • Prev Close1.45
  • 52 Week High3.29
  • 52 Week High Date06/29/23
  • 52 Week Low0.53
  • 52 Week Low Date12/06/23

Key Stats

  • Market Cap34.009M
  • Shares Out23.95M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-38.86

KEY STATS

  • Open1.37
  • Day High1.44
  • Day Low1.36
  • Prev Close1.45
  • 52 Week High3.29
  • 52 Week High Date06/29/23
  • 52 Week Low0.53
  • 52 Week Low Date12/06/23
  • Market Cap34.009M
  • Shares Out23.95M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-38.86

RATIOS/PROFITABILITY

  • EPS (TTM)-1.01
  • P/E (TTM)-1.40
  • Fwd P/E (NTM)-2.96
  • EBITDA (TTM)-11.396M
  • ROE (TTM)-646.98%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RenovoRx Inc

 

Profile

MORE
RenovoRx, Inc. is a clinical-stage biopharmaceutical company. The Company is developing targeted combination therapies for high unmet medical needs with a goal of improving therapeutic outcomes for cancer patients undergoing treatment. Its Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic intravenous therapy. Its portfolio of...
Ramtin Agah M.D.
Chairman of the Board, Co-Founder, Chief Medical Officer
Shaun Bagai
Chief Executive Officer, Director
Ronald Kocak CPA
Principal Financial Officer and Accounting Officer, Vice President, Controller
Address
333 W Santa Clara St Ste 900
San Jose, CA
95113-1716
United States

Top Peers

SYMBOLLASTCHG%CHG
CNTX
Context Therapeutics Inc
1.78-0.09-4.81%
ENLV
Enlivex Therapeutics Ltd
1.48-0.02-1.27%
UBX
UNITY Biotechnology Inc
1.56+0.03+1.96%
BIVI
BioVie Inc
0.4825-0.0037-0.761%
VIRX
Viracta Therapeutics Inc
0.80+0.04+5.2632%